Sarfaraz K. Niazi

Glad to announce the FDA accepting my petition prnewswire.com/news-releases/…

My paper, published yesterday, addresses a very difficult topic: how to understand empathy. Is it different between men and women? Read it. frontiersin.org/journals/psych…

This is to inform you all that I am not participating in this event. If you need any advice, write to me at niazi@niazi.com. It is all free. You can also read my paper that tells the whole story: mdpi.com/1424-8247/18/8…

Slowly, my views are gaining acceptance of how to be rational in developing biosimilars: managedhealthcareexecutive.com/view/the-fda-p…

📢#Specialissue: #Biosimilars #Development Strategies ⏰Deadline: 25 November 2025 🎓Guest Editors: Dr. Sarfaraz K. Niazi and Dr. Sesselja S. Ómarsdóttir 📖Find out more at mdpi.com/journal/pharma… @MDPIBiologySubj

@Pharmaceut_MDPI @MDPIBiologySubj I highly recommend all biosimilar stakeholders to make this a historic event; submit now!

So who is losing. What idiotic move.

Businesses across country remain closed in solidarity with Palestinians dawn.com/news/1906709

Full article: Contradicting rulings of the US patent office on double patenting jeopardize the generic and biosimilar drugs tandfonline.com/doi/full/10.10…